咖啡因通过腺A受体路径增强大鼠初级脂肪细胞中的脂解
K Konieczna1, K Szkudelska1, T Wojciechowicz1
1Department of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, Poznan, Poland.
概括
咖啡因通过阻断腺A1受体和激活蛋白激酶A (PKA) 来增强大鼠脂肪细胞中的脂肪分解 (脂解). 这种机制有助于减少脂肪积累.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 代谢过程中的代谢.
背景情况:
- 咖啡因是一种广泛消费的兴奋剂,具有潜在的代谢益处.
- 减少脂肪组织积累是咖啡因已知的作用,但潜在的机制尚不清楚.
- 脂解,即脂肪细胞中脂肪的分解,是脂肪代谢中的一个关键过程.
研究的目的:
- 为了研究咖啡因对隔离的老鼠脂肪细胞脂解的短期影响.
- 阐明咖啡因影响脂肪细胞脂解的分子机制.
- 确定腺A1受体和蛋白激酶A (PKA) 在咖啡因介导的脂解中的作用.
主要方法:
- 隔离的老鼠脂肪细胞被用咖啡因 (1毫米) 和各种脂解剂 (上腺素,福斯科林,迪布蒂瑞尔-cAMP,DPCPX) 治疗.
- 脂解量化是通过测量甘油释放量来量化.
- 与脂解相关的基因表达在mRNA水平上进行了分析.
- 通过使用PKA抑制剂H-89来评估PKA的参与.
主要成果:
- 咖啡因显著增强了上腺素,福斯科林和迪布图里尔-cAMP诱导的脂解.
- 咖啡因并没有改变单独使用DPCPX或与其他药物结合刺激的脂解.
- 咖啡因对上腺素诱导的脂解的刺激作用被H-89取消.
- 咖啡因稍微增加了细胞内cAMP水平,但没有影响与脂解相关的基因表达.
结论:
- 咖啡因促进大鼠脂肪细胞的脂解,主要是通过抑制腺A1受体信号通路.
- 该PKA信号通路对于咖啡因的脂解作用至关重要.
- 咖啡因诱导的脂解有助于减少脂肪细胞中的脂质积累.
相关概念视频
cAMP-dependent Protein Kinase Pathways
8.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.2K
Adrenergic Receptors: β Subtype
3.4K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.4K
GPCRs Regulate Adenylyl Cylase Activity
7.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K
Adrenergic Agonists: Indirect-Acting Agents
2.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K
Adrenergic Receptors (Adrenoceptors): Classification
4.6K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
4.6K
Adrenergic Agonists: Mixed-Action Agents
1.4K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.4K


